Pentagalloylglucose Triggers Ovarian Cancer Cell Senescence by Suppressing AKT Signaling
A preclinical study shows that pentagalloylglucose inhibits ovarian cancer cell growth and promotes senescence by targeting AKT2 for degradation.
A preclinical study shows that pentagalloylglucose inhibits ovarian cancer cell growth and promotes senescence by targeting AKT2 for degradation.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.